Reliance Industries Ltd (RIL), led by Mukesh Ambani, has spent $13 billion over the past 5 years on acquisitions in various sectors like clean energy, telecom, retail, and media. These investments mark a strategic shift from the company’s traditional oil and petrochemical focus to consumer-facing and green energy ventures.
Recently, Reliance acquired Karkinos Healthcare for ₹375 crore, strengthening its presence in the digital healthcare and diagnostics space. Karkinos, established in 2020, focuses on early cancer detection and management. It offers technology-driven solutions and collaborates with hospitals to provide affordable oncology services, including testing and radiation therapy.
The company has partnered with around 60 hospitals and is building a 150-bed cancer care hospital in Imphal, Manipur. Its revenue streams include diagnostics, distributed cancer care networks, corporate partnerships for early diagnosis, and cancer care hospital operations.
Reliance plans to integrate its technological capabilities and vast distribution network to transform healthcare. Initiatives include digital health platforms, telemedicine, and advanced healthcare delivery systems.
RIL’s strategy focuses on expanding its consumer-facing businesses and sustainable solutions while retaining profitability. Its diversification into healthcare and green energy reflects a vision of aligning business growth with societal needs.
Reliance Industries Limited is a large Indian company based in Mumbai, Maharashtra. It operates in various sectors, including energy, petrochemicals, natural gas, retail, entertainment, telecommunications, media, and textiles.
Reliance Industries share price is currently trading at ₹1,212.80, down by ₹2.65 (0.22%) as of 10:05 AM on January 1. The stock opened at ₹1,214.85, reached a high of ₹1,217.90, and a low of ₹1,211.60. The company’s market capitalisation is ₹16.41 lakh crore, with a P/E ratio of 24.17 and a dividend yield of 0.41%. The 52-week high and low are ₹1,608.80 and ₹1,201.50, respectively.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jan 1, 2025, 10:09 AM IST
We're Live on WhatsApp! Join our channel for market insights & updates